Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
26%

OVERLAP
BY WEIGHT
40

# OF OVERLAPPING
HOLDINGS
SBIO
87
HOLDINGS
49%
ALSO IN XBI
XBI
138
HOLDINGS
29%
ALSO IN SBIO
SECTOR DRIFT (SBIO minus XBI)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in SBIO
Weight
in XBI
Overlap
APOGEE THERAPEUTICS, INC. 4.5% 1.6% 1.6%
ORUKA THERAPEUTICS INC 3.0% 1.4% 1.4%
DIANTHUS THERAPEUTICS INC 3.0% 1.3% 1.3%
CG ONCOLOGY, INC. 3.3% 1.3% 1.3%
TRAVERE THERAPEUTICS, INC. 2.9% 1.2% 1.2%
SBIO Overweight Relative to XBI
CRINETICS PHARMACEUTICALS INC 4.7%
APOGEE THERAPEUTICS, INC. 2.9%
DEFINIUM THERAPEUTICS INC 2.5%
EDGEWISE THERAPEUTICS, INC. 2.4%
CG ONCOLOGY, INC. 2.0%
NEWAMSTERDAM PHARMA CO NV 1.9%
DIANTHUS THERAPEUTICS INC 1.7%
TRAVERE THERAPEUTICS, INC. 1.6%
MBX BIOSCIENCES INC 1.6%
ORUKA THERAPEUTICS INC 1.6%
SBIO Underweight Relative to XBI
ERASCA, INC. -1.4%
KYMERA THERAPEUTICS, INC. -1.4%
SPYRE THERAPEUTICS INC -1.4%
TWIST BIOSCIENCE CORP. -1.3%
REVOLUTION MEDICINES, INC. -1.3%
PROTAGONIST THERAPEUTICS, INC. -1.3%
COGENT BIOSCIENCES INC -1.3%
VIKING THERAPEUTICS, INC. -1.2%
BRIDGEBIO PHARMA, INC. -1.2%
ROIVANT SCIENCES LTD. -1.2%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY